KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Co-Diagnostics (CODX) Notes Payables (2017 - 2018)

Historic Notes Payables for Co-Diagnostics (CODX) over the last 2 years, with Q4 2018 value amounting to $1.9 million.

  • Co-Diagnostics' Notes Payables changed N/A to $1.9 million in Q4 2018 from the same period last year, while for Dec 2018 it was $1.9 million, marking a year-over-year change of. This contributed to the annual value of $1.9 million for FY2018, which is N/A changed from last year.
  • According to the latest figures from Q4 2018, Co-Diagnostics' Notes Payables is $1.9 million.
  • In the past 5 years, Co-Diagnostics' Notes Payables ranged from a high of $2.6 million in Q2 2017 and a low of $1.9 million during Q3 2018